newsfilter
← Latest News
ClinicalTrials.gov·

A Safety, Tolerability and Preliminary Efficacy Study of BBI-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis - NCT05382819

The number of participants with treatment-emergent adverse events.